Citi analyst Mohit Bansal initiates coverage on Forte Biosciences Inc. (NASDAQ: FBRX) with a Buy rating and a price target ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Hot Comments Hot New Coverage New Coverage

Forte Biosciences Inc. (FBRX) PT Raised to $103 at Brookline Capital MarketsMarch 24, 2021 3:03 PM Forte Biosciences Inc. (FBRX) PT Raised to $90 at Ladenburg Thalmann, Following EarningsMarch 24, 2021 1:12 PM Forte Biosciences (FBRX) Misses Q4 EPS by 17cMarch 24, 2021 8:03 AM Form 8-K Forte Biosciences, Inc. For: Mar 24March 24, 2021 8:02 AM Forte Biosciences, Inc. Announces 4Q and Full Year 2020 Results and Provides a General Business UpdateMarch 24, 2021 8:00 AM